Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits

Archives of Ophthalmology

Volumn 114, Issue 11, 1996, Pages 1390-1395

  Wilson, Thomas W ^a   Chan, Helen S L ^b,c   Moselhy, Galina M ^d   Heydt Jr , Duane D ^a   Frey, Carolin M ^a   Gallie, Brenda L ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Ontario Ministry of Labour   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CRYOTHERAPY; DRUG PENETRATION; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINOBLASTOMA; VITREOUS BODY;

EID: 0029912057     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140590011     Document Type: Article

References (32)

1. Zelter M, Gonzalez G, Schwartz L, et al. Treatment of retinoblastoma: results obtained from a prospective study of 51 patients. Cancer. 1988;61: 153-16.
2. White L. Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991;13:189-201.
3. Chan HSL, Canton MD, Gallie BL. Chemosensitivity and multidrug resistance antineoplastic drugs in retinoblastoma cell lines. Anticancer Res. 1989;9: 469-474.
4. Chan HSL, Thorner PS, Haddad G, Gallie BL. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology. 1991; 98:1425-1431.
5. Chan HSL, Thorner PS, Haddad G, Gallie BL. Effect of chemotherapy on intraocular retinoblastoma. Int J Pediatr Hematol Oncol. 1995;2:269-281.
6. Abramson DH. The focal treatment of retinoblastoma with emphasis on xenon arc photocoagulation. Acta Ophthalmol. 1989;194(suppl):3-63.
7. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108:260-264.
8. Abramson DH, Ellsworth RM, Tretter P, Adams K, Kitchin FD. Simultaneous bilateral radiation for advanced bilateral retinoblastoma. Arch Ophthalmol. 1981; 99:1763-1766.
9. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85:1121-1128.
10. Imhof SM, Hofman P, Tan KE. Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma. Br J Ophthalmol. 1993;77:482-484.
11. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiation. Arch Ophthalmol. 1996:114: 1321-1328.
12. Chan HSL, DeBoer G, Thiessen JJ, et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res. 1996;2:1499-1508.
13. Shields CL, De Potter P, Himelstein, et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330-1338.
14. Murphree AL, Villablanca JG, Deegan III WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348-1356.
15. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1339-1343.
16. Shields JA, Shields CL, De Potter P. Cryotherapy for retinoblastoma. Int Ophthalmol Clin 1993;33:101-105.
17. Sipperley JO, Machemer R. Histopathologic evaluation of adhesive properties of early lesions in diathermy and cryopexy. Dev Ophthalmol. 1981;2;297-301.
18. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989;6:695-698.
19. Beaulieu E, Demeule M, Pouliot J-F, Averill-Bates DA, Murphy GF, Béliveau R. P-glycoprotein of blood brain barrier: cross-reactivity of MAb C219 with a 190-kDa protein in bovine and rat isolated brain capillaries. Biochim Biophys Acta: Bio-Membranes. 1995;1233:27-32.
20. Schinkel AH, Smit JJM, Van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994;77:491-502.
21. Gerlach JH, Kartner N, Bell DR, Ling V. Multidrug resistance. Cancer Surv. 1986;5:25-46.
22. Gerlach JH, Endicott JA, Juranka PF, et al. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 1986;324:485-489.
23. Lee TW, Yang SW, Kim CM, Hong WS, Youn DH. Chemosensitization to adriamycin by cyclosporin A and verapamil in human retinoblastoma cell lines. J Korean Med Sci. 1993;8:104-109.
24. Slater LM, Sweet P, Stupecky M, Wetzel MW, Gupta S Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br J Cancer. 1986;54: 235-238.
25. Georges E, Sharom FJ, Ling V. Multidrug resistance and Chemosensitization: therapeutic implications for cancer chemotherapy. In: August T. Anders MW, Murad F, Nies A, eds. Advances in Pharmacology. San Diego, Calif: Academic Press; 1990:185-222.
26. Kashani-Sabet M, Wang W, Scanlon KJ. Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells, J Biol Chem. 1990; 265:11285-11288.
27. Morgan RJ Jr, Margolin K, Raschko J, et al. Phase I trial of carboplatin and infusional cyclosporine in advanced malignancy. J Clin Oncol. 1995;13:2238-2246.
28. Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc. 1969;67:462-534.
29. Theis JGW, Liau-Chu M, Chan HSL, Doyle J, Greenberg ML, Koren G. Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. J Clin Oncol. 1995;13:2508-2516.
30. Lum BL, Kaubisch S, Yahanda AM, et al. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol. 1992;10:1635-1642.
31. Erlichman C, Moore M, Thiessen JJ, et al. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin. Cancer Res. 1993;53:4837-4842.
32. Bartlett NL, Lum BL, Fisher GA, et al. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J Clin Oncol. 1994;12:835-842.